Stacey Pugh is the Chief Executive Officer at Endogenex. As a leader in Medical Technology, she has more than 15 years of experience in medical device research, development and commercialization. Stacey joined Butterfly in 2021 and leads the company in the planning, organization, and implementation of all sales and marketing activities. Prior to Butterfly, Stacey was President of Medtronic’s Neurovascular Operating Unit, where she provided overall global strategic leadership, guided marketing and business development and was responsible for revenue growth. Prior to this role, Stacey was Vice President and General Manager of Neurovascular & Cerebral Spinal Fluid (CSF) businesses and was responsible for leading the company’s European, Middle Eastern and African (EMEA) business programs and developing trade strategies to support the global revenue and market share growth of Medtronic Neurovascular products. In addition, Stacey held various leadership roles in Covidien’s Neurovascular division as Vice President of Global Medical Affairs where she provided strategic direction for all medical affairs activities and executed strategic market access plans. As a registered nurse, Stacey spent the early years of her career in research, critical care and trauma nursing, and nursing education.